| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11095-011-0549-8 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/s11095-011-0549-8/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/s11095-011-0549-8 | ||
| http://link.springer.com/content/pdf/10.1007/s11095-011-0549-8.pdf | ||
| https://europepmc.org/articles/PMC5012899 | ||
| https://europepmc.org/articles/PMC5012899?pdf=render | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012899 | ||
| P932 | PMC publication ID | 5012899 |
| P698 | PubMed publication ID | 21826573 |
| P5875 | ResearchGate publication ID | 51556946 |
| P50 | author | David Schaffer | Q59749936 |
| P2093 | author name string | David V. Schaffer | |
| Priya S. Shah | |||
| P2860 | cites work | Drug research. Roche exits RNAi field, cuts 4800 jobs | Q82616900 |
| Transcriptional and Posttranscriptional Plant Gene Silencing in Response to a Pathogen | Q95431973 | ||
| Hairpin RNA-mediated silencing of Plum pox virus P1 and HC-Pro genes for efficient and predictable resistance to the virus. | Q45422109 | ||
| Dual modes of RNA-silencing suppression by Flock House virus protein B2. | Q45423252 | ||
| Silencing of yellow head virus replication in penaeid shrimp cells by dsRNA. | Q45439835 | ||
| Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference | Q45634908 | ||
| Inhibition of hepatitis B virus expression and replication by RNA interference | Q45728501 | ||
| Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow | Q45887432 | ||
| Inhibition of drug-resistant HIV-1 by RNA interference | Q46806254 | ||
| Inhibition of respiratory viruses by nasally administered siRNA. | Q47874231 | ||
| Silencing of HTLV-1 gag and env genes by small interfering RNAs in HEK 293 cells | Q50527698 | ||
| Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing | Q50768291 | ||
| Inhibition of SARS-associated coronavirus infection and replication by RNA interference. | Q51641137 | ||
| Twenty years of therapy for HIV-1 infection | Q53382316 | ||
| Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs | Q53399030 | ||
| Chemical modification of siRNAs to improve serum stability without loss of efficacy | Q53600125 | ||
| HIV Drug Resistance | Q59448085 | ||
| Viral evolution under the pressure of an adaptive immune system: Optimal mutation rates for viral escape | Q59867771 | ||
| Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication | Q63561195 | ||
| Genome-scale RNAi screen for host factors required for HIV replication | Q79769455 | ||
| Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model | Q80439723 | ||
| Inhibition of herpesvirus-6B RNA replication by short interference RNAs | Q80832451 | ||
| Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs | Q80913745 | ||
| Inhibition of porcine circovirus type 2 replication in mice by RNA interference | Q82329354 | ||
| A similarity between viral defense and gene silencing in plants | Q34793599 | ||
| Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3. | Q34991742 | ||
| Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes | Q35022080 | ||
| Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration | Q35023698 | ||
| An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice | Q35111705 | ||
| Control of nonsegmented negative-strand RNA virus replication by siRNA. | Q35739895 | ||
| RNA silencing of rotavirus gene expression | Q35739901 | ||
| Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC | Q35990922 | ||
| Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing | Q36018096 | ||
| Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. | Q36186475 | ||
| Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. | Q36457063 | ||
| Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference | Q36483991 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy | Q36673668 | ||
| RNA interference directed against Poly(ADP-Ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells | Q36684320 | ||
| Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants | Q36708618 | ||
| Stability and loss of a virus resistance phenotype over time in transgenic mosquitoes harbouring an antiviral effector gene | Q36821669 | ||
| Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). | Q36954414 | ||
| Impact of target mRNA structure on siRNA silencing efficiency: A large-scale study | Q37135903 | ||
| The business of RNAi therapeutics | Q37147185 | ||
| A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity | Q37199509 | ||
| A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs | Q37331638 | ||
| Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency | Q37405760 | ||
| Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success | Q37417692 | ||
| Inhibition of monkeypox virus replication by RNA interference | Q37422402 | ||
| Rapid creation and quantitative monitoring of high coverage shRNA libraries | Q37440284 | ||
| Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis | Q37596477 | ||
| Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses | Q37657108 | ||
| Staying on message: design principles for controlling nonspecific responses to siRNA | Q37809577 | ||
| Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron | Q38621943 | ||
| Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance | Q38874585 | ||
| Combinatorial RNAi against HIV-1 using extended short hairpin RNAs | Q39502428 | ||
| Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors | Q39629447 | ||
| Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs | Q39696110 | ||
| The nuclear RNase III Drosha initiates microRNA processing | Q24295234 | ||
| Identification of host proteins required for HIV infection through a functional genomic screen | Q24306298 | ||
| Cellular cofactors affecting hepatitis C virus infection and replication | Q24317564 | ||
| MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function | Q24538996 | ||
| Animal virus replication and RNAi-mediated antiviral silencing in Caenorhabditis elegans | Q24542489 | ||
| mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes | Q24554481 | ||
| MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
| T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice | Q24603574 | ||
| Directed evolution of adeno-associated virus to an infectious respiratory virus | Q24649385 | ||
| On the origin and functions of RNA-mediated silencing: from protists to man | Q24657546 | ||
| MicroRNAs in plants | Q24674274 | ||
| Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans | Q24677038 | ||
| siVirus: web-based antiviral siRNA design software for highly divergent viral sequences | Q24680302 | ||
| Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production | Q24682936 | ||
| Sam68 is absolutely required for Rev function and HIV-1 production | Q24791042 | ||
| A theoretical approach to predicting the success of genetic manipulation of malaria mosquitoes in malaria control | Q24791629 | ||
| HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome | Q24802185 | ||
| A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites | Q24804835 | ||
| A single siRNA suppresses fatal encephalitis induced by two different flaviviruses | Q25255046 | ||
| Hepatitis C Virus Replicons Escape RNA Interference Induced by a Short Interfering RNA Directed against the NS5b Coding Region | Q27469608 | ||
| Engineering RNA interference-based resistance to dengue virus type 2 in genetically modified Aedes aegypti | Q27473167 | ||
| Interference of hepatitis C virus RNA replication by short interfering RNAs | Q27473349 | ||
| Alphavirus-derived small RNAs modulate pathogenesis in disease vector mosquitoes | Q27487509 | ||
| Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus | Q27488340 | ||
| Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing | Q27488834 | ||
| The role of RNAi and microRNAs in animal virus replication and antiviral immunity | Q27490179 | ||
| Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production | Q27490919 | ||
| A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA | Q27860813 | ||
| Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 | ||
| An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans | Q27860895 | ||
| Identification of Novel Genes Coding for Small Expressed RNAs | Q27860917 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| How cells respond to interferons | Q27861006 | ||
| Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
| LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 | Q28210584 | ||
| Purified Argonaute2 and an siRNA form recombinant human RISC | Q28242666 | ||
| Inhibition of translational initiation by Let-7 MicroRNA in human cells | Q28265842 | ||
| Second-generation shRNA libraries covering the mouse and human genomes | Q28275183 | ||
| A viral suppressor of gene silencing in plants | Q28286683 | ||
| Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms | Q28295748 | ||
| Development of a low bias method for characterizing viral populations using next generation sequencing technology | Q28748746 | ||
| Rational siRNA design for RNA interference | Q29614450 | ||
| Crystal structure of Argonaute and its implications for RISC slicer activity | Q29614980 | ||
| Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| Expression profiling reveals off-target gene regulation by RNAi | Q29615965 | ||
| Rates of evolutionary change in viruses: patterns and determinants | Q29616174 | ||
| RNA interference acts as a natural antiviral response to O'nyong-nyong virus (Alphavirus; Togaviridae) infection of Anopheles gambiae | Q29616263 | ||
| Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication | Q29616375 | ||
| RNA interference screen for human genes associated with West Nile virus infection | Q29616376 | ||
| Induction and suppression of RNA silencing by an animal virus | Q29618494 | ||
| Functional neurogenesis in the adult hippocampus | Q29618708 | ||
| Optimal design and validation of antiviral siRNA for targeting HIV-1. | Q30365737 | ||
| Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. | Q30384547 | ||
| Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell culture | Q30389699 | ||
| Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila | Q30556603 | ||
| Restriction enzyme-generated siRNA (REGS) vectors and libraries | Q33196416 | ||
| Enzymatic production of RNAi libraries from cDNAs. | Q33196418 | ||
| Small interfering RNA production by enzymatic engineering of DNA (SPEED) | Q33199649 | ||
| Designing siRNA that distinguish between genes that differ by a single nucleotide | Q33257088 | ||
| The Ebola virus VP35 protein is a suppressor of RNA silencing | Q33288729 | ||
| Comparison of chicken 7SK and U6 RNA polymerase III promoters for short hairpin RNA expression | Q33306167 | ||
| Host cell factors in HIV replication: meta-analysis of genome-wide studies | Q33455551 | ||
| Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. | Q33455759 | ||
| Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties | Q33628417 | ||
| Inhibition of SARS-CoV replication by siRNA. | Q45206542 | ||
| The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain | Q45280305 | ||
| Inhibition of Newcastle disease virus replication by RNA interference targeting the matrix protein gene in chicken embryo fibroblasts | Q45378471 | ||
| Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine | Q45388986 | ||
| Effective inhibition of infectious bursal disease virus replication in vitro by DNA vector-based RNA interference | Q45396139 | ||
| Inhibition of enterovirus 71 in virus-infected mice by RNA interference. | Q45401009 | ||
| Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery | Q45410987 | ||
| Development of potential antiviral strategy against coxsackievirus B4. | Q39730331 | ||
| Inhibition of Hepatitis E virus replication using short hairpin RNA (shRNA). | Q39747338 | ||
| Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus | Q39754286 | ||
| RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences | Q39816401 | ||
| Inhibition of rabies virus replication by multiple artificial microRNAs | Q39818328 | ||
| Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. | Q39843765 | ||
| Suppression of RNA silencing by Flock house virus B2 protein is mediated through its interaction with the PAZ domain of Dicer | Q39887463 | ||
| Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco | Q39909667 | ||
| RNA interference protects horse cells in vitro from infection with Equine Arteritis Virus | Q39917317 | ||
| HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. | Q39919699 | ||
| Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts | Q39979308 | ||
| Development of RNA interference (RNAi) as potential antiviral strategy against enterovirus 70. | Q39989780 | ||
| Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes | Q39992106 | ||
| Human immunodeficiency virus type 1 escape from RNA interference | Q40011912 | ||
| Specific small interfering RNAs-mediated inhibition of replication of porcine encephalomyocarditis virus in BHK-21 cells | Q40017520 | ||
| HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region | Q40037564 | ||
| Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome | Q40085164 | ||
| Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice | Q40089500 | ||
| Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs | Q40132466 | ||
| Inhibition of avian leukosis virus replication by vector-based RNA interference | Q40134516 | ||
| Inhibition of porcine circovirus type 1 and type 2 production in PK-15 cells by small interfering RNAs targeting the Rep gene | Q40139396 | ||
| Silencing of HIV-1 with RNA interference: a multiple shRNA approach | Q40234514 | ||
| The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference | Q40237024 | ||
| Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. | Q40250791 | ||
| Hepatitis B virus is inhibited by RNA interference in cell culture and in mice | Q40255282 | ||
| Interference of porcine reproductive and respiratory syndrome virus replication on MARC-145 cells using DNA-based short interfering RNAs. | Q40274880 | ||
| Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response | Q40306305 | ||
| Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome | Q40399935 | ||
| Impact of gene-modified T cells on HIV infection dynamics | Q40408633 | ||
| Drosophila U6 promoter-driven short hairpin RNAs effectively induce RNA interference in Schneider 2 cells | Q40424836 | ||
| Rotavirus gene silencing by small interfering RNAs | Q40429464 | ||
| RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. | Q40447169 | ||
| Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. | Q40454547 | ||
| Paradigms for conditional expression of RNA interference molecules for use against viral targets. | Q40472917 | ||
| La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. | Q40481133 | ||
| RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus | Q40501127 | ||
| Inhibition of foot-and-mouth disease virus replication by small interfering RNA. | Q40504597 | ||
| Inhibition of Marburg virus protein expression and viral release by RNA interference | Q40512402 | ||
| Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus | Q40534160 | ||
| Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus | Q40581785 | ||
| Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition | Q40589914 | ||
| Inhibition of human cytomegalovirus replication by small interfering RNAs | Q40600110 | ||
| Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo | Q40606944 | ||
| Enhanced gene silencing by the application of multiple specific small interfering RNAs | Q40628982 | ||
| Inhibition of hepatitis B virus in mice by RNA interference | Q40648698 | ||
| Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference | Q40695522 | ||
| Modulation of HIV-1 replication by RNA interference | Q40721798 | ||
| Short interfering RNA confers intracellular antiviral immunity in human cells | Q40721804 | ||
| Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches | Q40723068 | ||
| An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus | Q40834923 | ||
| Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips | Q42069867 | ||
| Emerging Influenza Antiviral Resistance Threats | Q42725866 | ||
| Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes | Q42739394 | ||
| Efficient regulation of viral replication by siRNA in a non-human primate surrogate model for hepatitis C. | Q43039541 | ||
| RNA interference in mammalian cells by chemically-modified RNA. | Q44496696 | ||
| Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation | Q44552994 | ||
| Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism | Q44572527 | ||
| Probing the sequence space available for HIV-1 evolution | Q44674520 | ||
| A novel program to design siRNAs simultaneously effective to highly variable virus genomes | Q44990767 | ||
| Quasispecies theory and the behavior of RNA viruses | Q33641547 | ||
| Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles | Q33658642 | ||
| Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library | Q33719287 | ||
| RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice | Q33730699 | ||
| An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells | Q33790771 | ||
| The cellular HIV-1 Rev cofactor hRIP is required for viral replication. | Q33926825 | ||
| A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus | Q33928650 | ||
| A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells | Q33938488 | ||
| Identification and characterization of human cytomegalovirus-encoded microRNAs | Q33987509 | ||
| RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma | Q34121209 | ||
| In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy | Q34221633 | ||
| siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells | Q34227843 | ||
| An antiviral role for the RNA interference machinery in Caenorhabditis elegans | Q34234621 | ||
| Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors | Q34246650 | ||
| Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands | Q34354192 | ||
| Enhanced activation of tax-dependent transcription of human T-cell leukemia virus type I (HTLV-I) long terminal repeat by TORC3. | Q34355955 | ||
| RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice | Q34437582 | ||
| Inhibition of influenza virus production in virus-infected mice by RNA interference | Q34514513 | ||
| Protection against lethal influenza virus challenge by RNA interference in vivo. | Q34514565 | ||
| Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways | Q34530552 | ||
| Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo | Q34545659 | ||
| Multiple shRNA combinations for near-complete coverage of all HIV-1 strains | Q34552467 | ||
| SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells | Q34558129 | ||
| MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs | Q34593731 | ||
| Transvascular delivery of small interfering RNA to the central nervous system. | Q34638044 | ||
| Molecular basis for target RNA recognition and cleavage by human RISC. | Q34654514 | ||
| RNAi-based therapeutics-current status, challenges and prospects | Q34659612 | ||
| Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes | Q34695803 | ||
| Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition | Q34733983 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | RNA interference | Q201993 |
| P304 | page(s) | 2966-2982 | |
| P577 | publication date | 2011-08-09 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Antiviral RNAi: translating science towards therapeutic success | |
| Antiviral RNAi: Translating Science Towards Therapeutic Success | |||
| P478 | volume | 28 |
| Q52587809 | A review on current status of antiviral siRNA. |
| Q36086410 | Antiviral Effects of Small Interfering RNA Simultaneously Inducing RNA Interference and Type 1 Interferon in Coxsackievirus Myocarditis |
| Q99237635 | Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? |
| Q38919000 | Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro |
| Q36937490 | Depletion of polycistronic transcripts using short interfering RNAs: cDNA synthesis method affects levels of non-targeted genes determined by quantitative PCR |
| Q39341096 | Down-regulation of viral replication by lentiviral-mediated expression of short-hairpin RNAs against vesicular stomatitis virus ribonuclear complex genes |
| Q34506213 | Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus |
| Q35001757 | Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers |
| Q38900126 | In vitro inhibition of field isolates of feline calicivirus with short interfering RNAs (siRNAs). |
| Q39220412 | RNA interference targets arbovirus replication in Culicoides cells |
| Q27014955 | Regulation of microRNA biogenesis and turnover by animals and their viruses |
| Q63407942 | Slicing and dicing viruses: antiviral RNA interference in mammals |
| Q24621942 | VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA |
| Q41847035 | VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses |
Search more.